CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 223542636
- Phone
- 2017502646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- Open-market buys, last 90 days
- $34,590
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$34,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-09 | Dash Barry H Director | Purchase | +100,000 | $0.26 | $26K | 3,365,555 |
| 2026-08-19 | Dash Barry H Director | Purchase | +30,000 | $0.29 | $9K | 3,265,555 |
| 2026-01-09 | Plassche Douglas EVP Operations | Option exercise | +2,500,000 | $0.03 | $75K | 6,000,000 |
| 2026-01-09 | Plassche Douglas EVP Operations | Option exercise · Stock Options (right to buy) | −2,500,000 | 0 | ||
| 2025-10-02 | Plassche Douglas EVP Operations | Sale | −800,000 | $0.62 | $499K | 3,500,000 |
| 2025-08-25 | ELITE PHARMACEUTICALS INC /NV/ EVP Operations | Option exercise | +2,500,000 | $0.03 | $75K | 4,300,000 |
| 2025-08-25 | ELITE PHARMACEUTICALS INC /NV/ EVP Operations | Option exercise · Stock Options (right to buy) | −2,500,000 | 2,500,000 | ||
| 2025-08-22 | ELITE PHARMACEUTICALS INC /NV/ EVP Operations | Sale | −500,000 | $0.52 | $262K | 1,800,000 |
| 2025-07-10 | Kirkov Kirko Chief Commercial Officer | Purchase | +16,366 | $0.59 | $10K | 16,366 |
| 2025-07-08 | Plassche Douglas EVP Operations | Sale | −200,000 | $0.58 | $116K | 2,300,000 |
| 2025-07-03 | Plassche Douglas EVP Operations | Option exercise | +2,500,000 | $0.03 | $75K | 2,500,000 |
| 2025-07-03 | Plassche Douglas EVP Operations | Option exercise · Stock Options (right to buy) | −2,500,000 | 5,000,000 | ||
| 2024-10-24 | Plassche Douglas SVP of Operations | Sale | −333,932 | $0.51 | $170K | 0 |
| 2024-10-23 | Plassche Douglas SVP of Operations | Sale | −800,000 | $0.49 | $392K | 333,932 |
| 2024-03-29 | Hakim Nasrat A CEO, President | Grant or award | +49,534,368 | 216,649,250 | ||
| 2023-12-29 | Hakim Nasrat A CEO, President | Grant or award | +2,223,147 | $0.07 | $153K | 2,223,147 |
| 2023-11-22 | WHITNELL JEFFREY A Director | Grant or award | +547,657 | $0.04 | $20K | 3,187,020 |
| 2023-11-22 | Caskey Davis S Director | Grant or award | +547,657 | $0.04 | $20K | 2,049,436 |
| 2023-11-22 | Dash Barry H Director | Grant or award | +547,657 | $0.04 | $20K | 3,235,555 |
| 2023-01-03 | Plassche Douglas Executive VP Operations | Grant or award · Options | +7,500,000 | $0.03 | $225K | 7,500,000 |
Page 1 of 8 · 159 trades